Financials

News Discussions Technicals Seasonals

688163 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to SHANGHAI SERUM BIO-TECHNOLOGY CO LT operating, investing, and financing activities

688163 free cash flow for Q1 25 is -23.18 M CNY. For 2024, 688163 free cash flow was 7.86 M CNY and operating cash flow was 67.22 M CNY.

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: CNY

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

TTM

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—